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1Abstract—A mini volume loading test (mVLT) method is
used for decision making in our prototype semi-closed loop
infusion system (SCLIS). The mVLT fluid protocol consists of
hemodilution response-guided mini fluid challenges. Each mini
fluid challenge (MFC) consists of a 2.5 ml kg-1–5 ml kg-1
crystalloid bolus infused over 2 min–5 min and followed by a
5 min period with no fluids. Arterial plasma dilution efficacy
(aPDE) of a MFC is calculated from invasively measured
hemoglobin (aHb) before and after each MFC. Capillary
plasma dilution efficacy (cPDE) is calculated from non-
invasively measured hemoglobin (SpHb). The zero or negative
arterio-capillary plasmadilution efficacy difference (acPED ≤ 0
p.d.u.) is an indication of hemodilution non-response and
imminent edema. However, it requires both invasive and non-
invasive hemoglobin measurements. A non-invasive assessment
of hemodilution response within the mVLT method would
increase its practical application and reduce costs further
enhancing its applicability in the SCLIS. This possibility exists
if the cPDE could reliably predict the acPED value or the
hemodilution response (the presence of acPED within a range of
> 0) or non-response (acPED ≤ 0).
We report a retrospective observational study in an elective
total knee arthoplasty (TKA) setting. The 2.5 ml kg-1 boluses
were used in six MFCs in both pre- and post-operative mVLT
sessions. The primary objective was to assess the accuracy of
cPDE in predicting the hemodilution response using the receiver
operating characteristic (ROC) curve and gray zone approaches.
Our secondary objective was to investigate the feasibility of a
statistical optimization method (SOM) in predicting the acPED.
The analysis included 480 paired values of cPDE and acPED.
The best cut-off value for cPDE was 0.015 p.d.u. (specificity =
0.84, sensitivity = 0.90). The gray zone identified a range of
cPDE values between 0.013 and 0.028 (p.d.u.) for which the
hemodilution response could not be indicated reliably. The
14 % of the cPDE values were in this range.
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The non-invasive evaluation of hemodilution response is
acceptably accurate in the perioperative TKA setting. The
mVLT algorithm within our prototype SCLIS was upgraded by
implementing the results of the present study.
Index Terms—ACDSS, SCLIS, mVLT, hemoglobin, fluids.
I. INTRODUCTION
A mini volume loading test (mVLT) is used for decision
making in a semi-closed loop infusion system (SCLIS) [1]–
[5]. The mVLT fluid protocol implies hemodilution guided
mini fluid challenges. These are 2.5 ml kg-1–5 ml kg-1
boluses infused over 2 min–5 min, each followed by a 5 min
period with no fluids. The assessment of hemodilution
response requires hemoglobin measures before and after
each mini fluid challenge (MFC). Hemoglobin in arteries
(invasive, aHb) and capillaries (non-invasive, SpHb) are
used to calculate the arterial and capillary plasma dilution
efficacies (aPDE and cPDE, respectively) and arterio-
capillary plasmadilution efficacy difference (acPED) [1],
[3]. Based on observations in  healthy volunteers [1] and
patients [2], a transcapillary reflux model suggests that
acPED ≤ 0 p.d.u. is an indication hemodilution non-
response and imminent edema. This signifies that fluid
loading should be stopped. However, the need for invasive
measurements is a major drawback in the clinical
implication of our novel automated clinical decision support
system (ACDSS) and the SCLIS [3]–[5]. A solely non-
invasive assessment of hemodilution response would be
possible if the cPDE could reliably predict the acPED value
or the hemodilution response (the presence of acPED value
within a range of acPED > 0) or non-response (acPED ≤ 0).
The primary objective was to assess the accuracy of cPDE
in predicting the hemodilution responsiveness using the
receiver operating characteristic (ROC) curve and gray
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zone approaches [6]. The secondary objective was to
investigate the feasibility of a statistical optimization method
(SOM) in predicting the acPED using the measured cPDE.
II. MATERIALS AND METHODS
We retreived and retrospectively analysed data from our
previous randomized controlled trial (Clinicaltrials.Gov,
identifier: NCT01355900) in patients who had elective
primary total knee arthroplasty (TKA) surgery [2], [7]. The
adhesive spectrophotometric sensor (ReSposable R2-25a;
Masimo Inc., Irvine, CA) connected to the Radical-7 Pulse
CO-Oximeter (Masimo Inc.; software version 7.6.2.1) was
used to measure SpHb. A radial artery cannula was placed in
the same arm on which the sensor was attached. This line
was used to extract blood for the analysis of aHb by CO-
Oximetry (COULTER® LH750, Beckman Coulter Inc.,
Chicago, IL) with a coefficient of variation ≤ 0.8 %. An
antecubital cannula for infusion was placed in the same arm.
(a)
(b)
Fig. 1. The invasively (arterial, aPDE) and non-invasively (capillary,
cPDE) measured plasma dilution efficacies of six mini fluid challenges. (a)
Pre-operative mVLT session, and (b) post-operative mVLT session. Data
are presented as means ± SEM.
The stepwise infusion was administered according to a
revised goal directed therapy (revGDT) protocol consisting
of conventional GDT supplemented by the mVLT [2]. The
cPDE and acPED were obtained in 48 subjects who had two
mVLT sessions – before the induction of anesthesia (pre-
operative session) and again 24 hours later (post-operative).
In each mVLT session they received six MFCs with
2.5 ml kg-1 boluses of Ringer’s acetate solution. The aHb
and SpHb were measured immediately before and after each
MFC. These variables were used to calculate aPDE, cPDE
(Fig. 1) and acPED (Fig. 2) using the Windows® platform-
based software of our prototypes ACDSS and SCLIS [3]–
[5].
Fig. 2. Arterio-capillary plasmadilution efficacy difference (acPED).
Differences between invasively (arterial) and non-invasively (capillary)
determined plasma dilution efficacies of each of the six mini fluid
challenges. Data are presented as means ± SEM.
III. STATISTICAL ANALYSIS
A. Sample Size
As previously suggested [8], assuming that 50 % of MFCs
are likely to be hemodilution ‘responder’ cases, a total of
200 MFCs would be necessary for the reliable determination
of the ROC curve and cut-off value. With an aim to perform
bootstrapping, we included data from 480 MFCs, a number
close to the previously used sample size [9]. We analysed
the pooled data related to the last five MFCs in each of the
two perioperative mVLT sessions in 48 subjects. Thus, there
were 480 paired values of cPDE and acPED from 96 mVLT
sessions. The MFCs were divided in 2 groups according to
the acPED: the hemodilution responders were defined as
acPED > 0 and non-responders as acPED ≤ 0.
B. Receiver Operating Characteristic (ROC) Curve
A receiver operating characteristic (ROC) curve (Fig. 3)
was created to assess the discriminative power of cPDE to
predict the presence of the acPED value within a range of
hemodilution non-response (acPED ≤ 0). The area under the
ROC curve was also created by using bootstraping [9], [10].
It creates multiple samples (1,000) by randomly drawing
instances from the study population. Since the unique best
58
ELEKTRONIKA IR ELEKTROTECHNIKA, ISSN 1392-1215, VOL. 22, NO. 1, 2016
cut-off cPDE value cannot be obtained by the bootstrap
method, the best cut-off value with the ROC curve was
obtained without bootstrap.
C. Threshold and Gray Zone Determination
The gray zone approach [6], [9], [11]–[13] was used to
determine a range of cPDE for which no conclusion may be
drawn concerning hemodilution response. We used a two-
step procedure. In the 1st step, the best threshold for cPDE
was determined in a bootstrapped population. The 95 % CI
of the best threshold was defined using the distribution of the
thresholds [2]. The best threshold for the ROC curve was
defined as that which maximizes the Youden index
(sensitivity + specificity −1).
(a)
(b)
Fig. 3. Bootstrapping of the receiver operator characteristics (ROC) curves
and gray zone determination for capillary plasma dilution efficacy (cPDE).
(a) Bootstrapped ROC curves, (b) average ROC curves representing the
discriminative power of cPDE to predict the hemodilution non-response
specific arterio-capillary pasmadilution efficacy difference (acPED ≤ 0) of
a mini fluid challenge. Box plots represent the distribution of the ROC
curves for the 1,000 resampled populations.
The aim of the 2nd step was to determine the cPDE values
for which no conclusive information could be provided. The
two-curve representation illustrates this step (Fig. 4(a)). We
defined inconclusive values with the sensitivity of < 90 %
and specificity < 90 %. The gray zone was defined as the
values that comply with a 10 % diagnostic tolerance. When
the characteristics of the study population produced a 95 %
CI of the best threshold and it is larger than the inconclusive
zone, the values obtained during the first step were retained
as the gray zone. The two-curve representation illustrates
this step (Fig. 4(a)). As previously applied to prediction of
fluid responsiveness for the flow-related dynamic target
parameters in GDT [9], the optimal threshold for cPDE to
predict the hemodilution non-response was then determined
as the one that minimized the explicit cost ratio (R = 1),
which is equivalent to maximizing the Youden’s index. By
determining this value for all the 1,000 resampled variables,
a distribution for the optimal thresholds of the 1,000 samples
was obtained. The optimal threshold was 0.015, and the
95 % CI of this distribution (the gray zone) was 0.013–
0.027. Considering that the determination of the gray zone is
prone to slightly different results between assessments [9],
the results of the two approaches were merged as a gray
zone from 0.013 to 0.028 (p.d.u.).
(a)
(b)
Fig. 4. Gray zone of the capillary plasma dilution efficacy (cPDE). Based
on the data from (a) 480 mini fluid challenges using the 2.5 ml kg-1
boluses, and (b) 144 mini fluid challenges using the 5 ml kg-1 boluses of
acetated Ringer’s solution. Blue curve: sensitivity; red curve: specificity.
We used the SOM as an alternative method for predicting
hemodilution response by calculating the predicted acPED.
IV. STATISTICAL OPTIMIZATION METHOD (SOM)
The SOM was based on the inverse relationship between
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cPDE and acPED in individual patient’s records (Fig. 5).
(a)
(b)
(c)
Fig. 5. One patient’s (PID n. 26) trends of hemodilution response in five
mini fluid challenges with 2.5 ml kg-1 boluses in two perioperative mVLT
sessions. (a) The recorded (actual) pre- and post-operative capillary plasma
dilution efficacy (cPDE), (b) pre-operative, and (c) post-operative actual
and SOM predicted, with or without offset, arterio-capillary plasmadilution
efficacy difference (acPED).
The SOM was applied to calculate the predicted acPED
value (acPEDsom) from the non-invasively measured (actual)
cPDE by using two approaches:
1. Invertion of the cPDE
 .somacPED cPDE  (1)
2. Applying an offset (coefficient)
 – ,of of of somacPED K cPDE K acPED   (2)
where Kof – empiric coefficient determined by the brute-
force search method.
The proportion of hemodilution response patterns was
compared between the actual (based on the measured
acPED) and the predicted (based on the calculated
acPEDsom and acPEDof) hemodilution responses. Chi-square
test was used to compare proportions of actual and predicted
hemodilution responses in all approaches. The statistical
analysis was performed with SAS 9.2 (SAS Institute Inc.,
Cary, NC). Results are expressed according to variable
distributions (mean and 95 % CI) or median [25th; 75th
percentiles] for quantitative variables.
V. RESULTS
Data from 48 TKA patients (41 women) were analysed.
Subjects were 69.5 (6.0) years old, their height (m) was 1.62
[1.56 to 1.65], weight (kg) was 87.0 [75.5 to 97.5] and the
body mass index (BMI, kg/m2) was 33.5 [31.0 to 35.1]. We
analyzed cPDE and acPED records, 480 values of each. The
variables were recorded during five mini fluid challenges in
each of the 48 pre- and 48 post-operative mVLT sessions.
A. The ROC Curve and Gray Zone Approaches
The area under the ROC curve with 95 % CI was 0.936
(CI: 0.915 to 0.958). The best cut-off value for cPDE was
0.015 (specificity = 0.84, sensitivity = 0.90, positive
likelihood ratio = 8.34, negative likelihood ratio = 0.12).
The 95 % CI for the best threshold value was 0.013 to 0.027
(p.d.u.). The results of the ROC curve and gray zone
approaches were merged and suggested a range of
inconclusive cPDE values from 0.013 to 0.028 (p.d.u.). The
two-curve representation is used to illustrate this approach
(Fig. 4(a)). There were 69 (14 %) cPDEs in this gray zone.
There were 184 (38.3 %) cPDEs below this threshold. The
previous version of mVLT algorithm [2] was then revised by
implementing these findings (Fig. 5). The software of our
prototype ACDSS within SCLIS [3], [4] was upgraded,
accordingly (Fig. 7).
B. Actual Hemodilution Response
The actual acPED ≤ 0 (p.d.u.) was found in 296 (61.7 %)
of the mini fluid challenges defined as non-responders.
There were 82 (34.2 %) responders in pre-operative, and
102 (42.5 %) in post-operative mVLT sessions. There were
158 (65.8 %) non-responders in pre-operative, and 138
(57.5 %) in post-operative sessions.
There was no difference between the proportions of
response patterns in pre- and post-operative mVLT sessions:
there were 82 pre-operative MFCs with acPED ≤ 0 and 158
with acPED > 0 while there were 102 post-operative MFCs
with acPED ≤ 0 and 138 with acPED > 0 (P = 0.074).
C. SOM Predicted Hemodilution Response
We found that 91 (18.9 %) acPEDsom was in the range of
hemodilution ‘response’ (acPEDsom > 0 p.d.u.) and 389
(81.1 %) were in the range of ‘non-response’ (acPEDsom ≤
0).
Also, 181 (37.7 %) acPEDof was a responder (acPEDof >
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0 p.d.u.) and 299 (62.3 %) was non-responder (acPEDof ≤
0).
D. Actual vs. SOM Predicted Hemodilution Response
The number of actual and SOM predicted (acPEDsom) was
n1 = 480 and n2 = 480, and the proportion of response
patterns was p1 = 184 and p2 = 91, respectively. There was a
statistically significant difference (P = 3.16*10-11).
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Crystalloid bolus of
2.5-5 ml/kg over 2-5 min.
5 min steady state without
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SpHb - non-invasive total hemoglobin (Pulse CO-Oximetry),
cPDE - capillary plasma dilution efficacy,
SOM - statistical optimization method to ameliorate the SpHb-precision
related fluctuations in cPDE.
Data processing: SOM
Calculate cPDE using SpHb and adjusted
cPDE using SOM-adjusted SpHb
Crystalloid bolus of
2.5-5 ml/kg over 2-5 min.
cPDE within a
non-response range ?
Stop boluses
Yes
cPDE increase ?
No
Yes
No
Fig. 6. The mini volume loading test (mVLT) algorithm.
The 0.015 offset (Kof = 0.015) was used in the calculation
of acPEDof (2). The number of samples was n1 = 480, n2 =
480, and the proportions of hemodilution response patterns
were p1 = 184, p2 = 181, respectively. There was no
significant difference between the proportions (P = 0.849).
VI. DISCUSSION
This retrospective observational study used the ROC
curve and gray zone approaches to examine the accuracy of
cPDE in the evaluation of hemodilution response to mini
fluid challenges with crystalloids in the mVLT protocol.
Our results show the three patterns of the cPDE predicted
hemodilution responses: negative, inconclusive and positive.
The gray zone approach has proposed two cut-offs: subjects
with a cPDE > 0.028 p.d.u. exclude positive response with
near certainty (negative response), whereas one with a cPDE
< 0.013 p.d.u. will nearly always respond to a MFC (positive
response). The cPDE between 0.013 and 0.028 (p.d.u.)
cannot reliably predict the response (inconclusive response).
There were 14 % MFCs with inconclusive cPDE predictions
of response in two perioperative mVLT sessions.
The area under the ROC curve for cPDE (Fig. 3) was the
first approach in our analysis. The ROC curve was created
by using a bootstrap methodology which limits the impact of
outliers [9], [10], but the best cut-off value (0.015 p.d.u.)
was obtained without bootstrapping. The second approach
was the gray zone method. This approach was proposed to
avoid the binary constraint of a “black-or-white” decision of
the ROC curve approach that often does not fit the reality of
clinical practice [6].
Fig. 7. Revised decision making in an automated clinical decision support
system (ACDSS) within the semi-closed loop infusion system (SCLIS).
In this study, we also used a previously proposed ratio of
costs (R) defined as R = false positive cost/false negative
cost [9]. The R < 1 denotes that not treating a false-negative
result is worse than treating a false-positive result which may
lead to unnecessary fluid loading [potential risk/fluid
overload]. The R > 1 denotes that to treat a false-positive
result is worse than to miss a false-negative [9]. The results
of both approaches were merged as a gray zone for cPDE
from 0.013 to 0.028 (p.d.u.). The two-step procedure in the
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gray zone approach was used with an aim to minimize the
impact of potential outliers.
A difference between the aPDE and cPDE, the acPED, is
dependent on the interaction between a transcapillary fluid
filtration–absorption ratio (FAR) which affects hemodilution
in capillaries, and net fluid elimination which affects the
hemodilution in arteries. The acPED may decrease when the
aPDE decreases, e.g., due to activation of renal elimination,
and/or when the cPDE increases due to an increase in fluid
shift from tissues to capillaries (increase in FAR). Therefore,
since activation of renal elimination requires about 20 min,
and distribution of crystalloid throughout the extracellular
fluid space requires about 30 min for completion [14], we
have excluded the first mini fluid challenge related data from
the present analysis.
Despite the obvious possibility of different combinations
of the FAR and net fluid elimination rate, the revised mVLT
algorithm (Fig. 6) implies that fluid loading is not indicated
when hemodilution in capillaries is higher than in arteries as
suggested by cPDE > 0.028 p.d.u., according to the results
of the present study. The background concept of the mVLT
is depicted on physiological basis in the transcapillary reflux
model [1], [2]. It explains the changes in acPED during the
incremental hemodilution in the the context of changes in
viscoelastic properties of the tissues that surround capillaries
and the rate of systemic fluid elimination from circulation.
The phenomenon of negative acPED is explained by the
level of tissue hydration in which interstitium releases
excessive fluid into capillaries during the 5 min period with
no fluids after a bolus. Our model, which is described in
detail within previous reports [1], [2], is similar to the
recently proposed ‘physiological model’ outlined within the
‘Discussion’ of the retrospective analysis of data from
previous volume kinetic studies in healthy volunteers and
patients [14]. The feasibility of the models needs evidence
from the direct measurments of changes in pertinent tissues
as they expand during the goal directed fluid infusion.
Further research in this area is urgently required.
We used the findings of our present study to upgrade the
mVLT algorithm (Fig. 6) in our Windows® platform-based
software of the prototype SCLIS [3]-[5] (Fig. 7). We defined
the positive hemodilution response as cPDE < 0.013 p.d.u.
since it predicts the acPED > 0 p.d.u.. However, according
to the mVLT method, both cPDE < 0.013 p.d.u. and acPED
> 0 p.d.u. may be observed in both under- and over-
hydration states. Thus, a static cPDE value is not a reliable
factor when deciding on the need for additional MFCs.
Meanwhile, a trend of cPDE can provide useful insights,
e.g., boluses are indicated if cPDE within that range
decreases, but should be stopped if cPDE increases.
Moreover, in cases when the cPDE is within the gray zone
during several consecutive MFCs, it remains unclear as to
how many MFCs are feasible. Theoretically, boluses could
be indicated if the cPDE within the gray zone decreases, but
should be stopped if it increases. Future research into this
issue is needed.
The off-label use of Pulse CO-Oximetry for non-invasive
measurement of capillary hemodilution remains an isue that
has to be addressed in discussions with industry in the light
of current evidence that non-invasive SpHb cannot reliably
predict hemoglobin concentration in large vessels [15].
VII. CLINICAL IMPLICATIONS
When a given value of cPDE is in the gray zone,
physicians cannot use this index as a factor in deciding
whether to proceed with or to exclude the need for additional
mini fluid challenges. Conversely, when a measured value is
outside of the gray zone, the necessity of performing a fluid
challenge can be confirmed (value above the upper limit of
the grey zone) or excluded (value below the lower limit of
the gray zone) with less than 10 % chance of error
(specificity and sensitivity > 90 %). At the bedside, the gray
zone appears to be more informative than the confidence
interval of the best threshold value obtained using the ROC
curve method.
The future implications of the mVLT within the revGDT
protocol and SCLIS may include the evaluation of the body
hydration levels and detection of imminent edema during
infusion, as well as monitoring the redistribution of fluids
following administration of a diuretic. These expectations
are supported by previous reports that mVLT method was
able to discriminate between differrent levels of hydration
status in healthy volunteers who received 3 mini fluid
challenges with the 2.5 ml kg-1 boluses of Ringer’s acetate
[1] and detect pre-operative dehydration in 36 TKA patients
who received 3 mini fluid challenges with the 5 ml kg-1
boluses of the same crystalloid [2]. In 48 TKA patients, who
received six 2.5 ml kg-1 boluses of Ringer’s acetate in pre-
and post-operative mVLTs, the positive 24-h fluid balance
and higher arterio-capillary plasma dilution difference in
pre-operative mVLT compared to post-operative suggested
higher post-operative hydration level [16]. These results are
consistent with the findings of our present study. We
retrospectively analysed data that was obtained in 5 out of 6
mini fluid challenges in these 48 TKA patients and found
that there was a trend towards lower number of negative
hemodilution responses in pre-operative mVLT compared to
post-operative: 82 pre- vs. 102 post-operative MFCs with
the acPED ≤ 0 (P = 0.074).
VIII. KEY MESSAGES
 In 480 measurements, a gray zone approach showed that
cPDE cannot reliably predict hemodilution response when
its value is between 0.013 and 0.028 (p.d.u.).
 In the TKA surgery setting, about 14 % of mini fluid
challenges with the 2.5 ml kg-1 boluses of a crystalloid
had the cPDE values within a gray zone.
 An isolated value of cPDE should be considered as a
tool rather than a target for titrating the fluid infusion.
Future studies are necessary to evaluate the feasibility of
targeting cPDE as a resuscitation endpoint.
IX. CONCLUSIONS
The non-invasive evaluation of hemodilution response is
acceptably reliable in perioperative TKA setting. The mVLT
algorithm within the prototype SCLIS was upgraded by
implementing the results of the present study.
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APPENDIX A
We have retrieved and pooled the data from the first part
of the primary RCT [7] where 3 mini fluid challenges with
the 5 ml kg-1 boluses of Ringer’s acetate were used in each
of the 36 pre- and 36 post-operative mVLT sessions [2].
Since we analysed only the data from the last two MFCs
(second and third), a total of 144 measures were analysed.
The cut-off cPDE value was 0.026 p.d.u. (specificity = 0.93,
sensitivity = 0.77). The gray zone was a range of cPDE
values between 0.015 and 0.080 (p.d.u.) (Fig. (b)). The
difference in findings compared to the ones based on the 480
measures in 48 patients may be related to the use of a twice
larger volume (doubled) but smaller number of boluses.
However, the significantly smaller sample size (144 vs. 480)
is probably the main source of discrepancy. Future research
is needed for more conclusive results.
Previously, data from 36 subjects who received three 5 ml
kg-1 boluses have been published addressing blood loss [7],
accuracy of non-invasive SpHb measurements [3] and the
use of the mVLT to detect pre-operative dehydration [2].
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